<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03710161</url>
  </required_header>
  <id_info>
    <org_study_id>608-18-FB</org_study_id>
    <nct_id>NCT03710161</nct_id>
  </id_info>
  <brief_title>Effect of Vitamin D Supplementation on Balance in CKD</brief_title>
  <official_title>Effect of Vitamin D Supplementation on Balance in Patients With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 2009, ~6% of the annual Medicare budget was spent to treat people with end-stage renal&#xD;
      disease on dialysis (ESRD5D), making chronic kidney disease (CKD) an important and costly&#xD;
      health problem affecting the United States. These patients are 4-5x more likely to suffer&#xD;
      from a fracture. Fractures can occur spontaneously but typically occur after a fall. Further,&#xD;
      70-90% of patients with ESRD5D are vitamin D deficient. Vitamin D supplementation has become&#xD;
      routine care for many in this patient population; without evidence to support this practice.&#xD;
      While studies on the elderly document the effect of vitamin D in decreasing fall risk,&#xD;
      findings are inconclusive for those elderly individuals with ESRD5D. The proposed projects&#xD;
      objective is to gather needed preliminary data regarding the effects of vitamin D&#xD;
      supplementation on balance and muscle strength in patients with ESRD5D. Thirty patients with&#xD;
      ESRD5D will be recruited and randomized into two groups: 1) 4000 or 2) 800 IU oral, vitamin D&#xD;
      taken daily. Men and women (ages 21-70 years) will be recruited from among patients receiving&#xD;
      hemodialysis at a UNMC-directed dialysis facility. Other inclusion criteria include 1) likely&#xD;
      to be able to complete the study; 2) ambulatory, without a walking aid; 3) able to complete&#xD;
      questionnaires interactively with a research nurse; and 4) greater than 3 months on&#xD;
      hemodialysis. Exclusion criteria include patients on peritoneal dialysis, allergy to vitamin&#xD;
      D, liver disease, intestinal disorders that would interfere with vitamin D absorption;&#xD;
      vitamin D supplements &gt;800 IU per day, glucocorticoids, anticonvulsants, drug therapies for&#xD;
      osteoporosis. All patients will be receiving standard of care per their nephrologist.&#xD;
      Functional data will be collected at baseline, three, and six months. Data collected will&#xD;
      include balance, muscle strength, and falls. Data to monitor vitamin D levels and calcium&#xD;
      will be pulled from their medical record. There is no follow up after the six month long&#xD;
      study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study was stopped due to the COVID pandemic&#xD;
  </why_stopped>
  <start_date type="Actual">July 8, 2019</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Timed up and go</measure>
    <time_frame>Baseline</time_frame>
    <description>This measures fall risk. The measure is a length of time it takes to complete a walking test. A longer score indicates a longer amount of time to complete the test. A shorter amount of time is considered better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fullerton Advanced Balance Scale</measure>
    <time_frame>Baseline</time_frame>
    <description>This 10 item assessment measures one's balance. Scores can range between 0-40. A score of 40 is considered the best performance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gait Speed Over 20 Meters</measure>
    <time_frame>Baseline</time_frame>
    <description>Walking speed is measured over distance of 20 meters. Walking speed is measured in meters per second. A faster walking speed is considered better. Time in seconds needed to cover 20 meters while walking is reported.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Strength of the Quadriceps (Right Leg)</measure>
    <time_frame>Baseline</time_frame>
    <description>Muscle strength of the muscles in the thigh will be measured using an isokinetic dynamometer. Strength is measured by the amount of force (peak torque) and will be divided by body mass (kg). Strength is reported as a percent of body weight. A greater peak torque percentage is considered better.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <condition>Kidney Failure, Chronic</condition>
  <arm_group>
    <arm_group_label>4000 IU Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4000 IU Vitamin D taken daily for six months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>800 IU Vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800 IU Vitamin D taken daily for six months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Vitamin D taken in two different dosages daily for six months.</description>
    <arm_group_label>4000 IU Vitamin D</arm_group_label>
    <arm_group_label>800 IU Vitamin D</arm_group_label>
    <other_name>25(OH)D</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  must be likely to be able to complete the study&#xD;
&#xD;
          -  must be able to walk without a walking aid&#xD;
&#xD;
          -  must be able to complete questionnaires interactively research staff&#xD;
&#xD;
          -  must have been on dialysis for greater than 3 months&#xD;
&#xD;
          -  all patients must be receiving standard of care per their nephrologist&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  peritoneal dialysis&#xD;
&#xD;
          -  an allergy to vitamin D&#xD;
&#xD;
          -  liver disease&#xD;
&#xD;
          -  intestinal disorders that would interfere with vitamin D absorption&#xD;
&#xD;
          -  taking vitamin D supplements &gt;800 IU per day, glucocorticoids, anticonvulsants, or&#xD;
             other drug therapies for osteoporosis&#xD;
&#xD;
          -  are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Nebraska at Omaha</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68182</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 15, 2018</study_first_submitted>
  <study_first_submitted_qc>October 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2018</study_first_posted>
  <results_first_submitted>April 27, 2021</results_first_submitted>
  <results_first_submitted_qc>May 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2021</results_first_posted>
  <last_update_submitted>May 18, 2021</last_update_submitted>
  <last_update_submitted_qc>May 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Jenna Yentes, PhD</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>dialysis</keyword>
  <keyword>end stage renal disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>De -identified data will be published as supplementary data to manuscripts.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 27, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/61/NCT03710161/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>4000 IU Vitamin D</title>
          <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
        <group group_id="P2">
          <title>800 IU Vitamin D</title>
          <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">Study halted due to COVID pandemic</participants>
                <participants group_id="P2" count="0">Study halted due to COVID pandemic</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Study halted due to COVID pandemic</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>4000 IU Vitamin D</title>
          <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
        <group group_id="B2">
          <title>800 IU Vitamin D</title>
          <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="5"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.3" spread="5.7"/>
                    <measurement group_id="B2" value="48.5" spread="5.5"/>
                    <measurement group_id="B3" value="55.6" spread="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (cm)</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174.7" spread="5.0"/>
                    <measurement group_id="B2" value="166.5" spread="2.5"/>
                    <measurement group_id="B3" value="171.7" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Mass (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.0" spread="21.5"/>
                    <measurement group_id="B2" value="112.3" spread="22"/>
                    <measurement group_id="B3" value="103.1" spread="22.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Resting HR</title>
          <units>bpm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.3" spread="12.3"/>
                    <measurement group_id="B2" value="69" spread="1"/>
                    <measurement group_id="B3" value="69.2" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Timed up and go</title>
        <description>This measures fall risk. The measure is a length of time it takes to complete a walking test. A longer score indicates a longer amount of time to complete the test. A shorter amount of time is considered better.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4000 IU Vitamin D</title>
            <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
          <group group_id="O2">
            <title>800 IU Vitamin D</title>
            <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
        </group_list>
        <measure>
          <title>Timed up and go</title>
          <description>This measures fall risk. The measure is a length of time it takes to complete a walking test. A longer score indicates a longer amount of time to complete the test. A shorter amount of time is considered better.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" spread="5.2"/>
                    <measurement group_id="O2" value="9.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fullerton Advanced Balance Scale</title>
        <description>This 10 item assessment measures one's balance. Scores can range between 0-40. A score of 40 is considered the best performance.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4000 IU Vitamin D</title>
            <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
          <group group_id="O2">
            <title>800 IU Vitamin D</title>
            <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
        </group_list>
        <measure>
          <title>Fullerton Advanced Balance Scale</title>
          <description>This 10 item assessment measures one's balance. Scores can range between 0-40. A score of 40 is considered the best performance.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.3" spread="6.9"/>
                    <measurement group_id="O2" value="34" spread="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Gait Speed Over 20 Meters</title>
        <description>Walking speed is measured over distance of 20 meters. Walking speed is measured in meters per second. A faster walking speed is considered better. Time in seconds needed to cover 20 meters while walking is reported.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4000 IU Vitamin D</title>
            <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
          <group group_id="O2">
            <title>800 IU Vitamin D</title>
            <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
        </group_list>
        <measure>
          <title>Gait Speed Over 20 Meters</title>
          <description>Walking speed is measured over distance of 20 meters. Walking speed is measured in meters per second. A faster walking speed is considered better. Time in seconds needed to cover 20 meters while walking is reported.</description>
          <units>seconds (Time in seconds to walk 20m)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.2" spread="6.6"/>
                    <measurement group_id="O2" value="20.0" spread=".7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Strength of the Quadriceps (Right Leg)</title>
        <description>Muscle strength of the muscles in the thigh will be measured using an isokinetic dynamometer. Strength is measured by the amount of force (peak torque) and will be divided by body mass (kg). Strength is reported as a percent of body weight. A greater peak torque percentage is considered better.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>4000 IU Vitamin D</title>
            <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
          <group group_id="O2">
            <title>800 IU Vitamin D</title>
            <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
          </group>
        </group_list>
        <measure>
          <title>Strength of the Quadriceps (Right Leg)</title>
          <description>Muscle strength of the muscles in the thigh will be measured using an isokinetic dynamometer. Strength is measured by the amount of force (peak torque) and will be divided by body mass (kg). Strength is reported as a percent of body weight. A greater peak torque percentage is considered better.</description>
          <units>percent body weight</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.9" spread="39.7"/>
                    <measurement group_id="O2" value="55.3" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Subjects were under supervision for chronic kidney disease by physician</desc>
      <group_list>
        <group group_id="E1">
          <title>4000 IU Vitamin D</title>
          <description>4000 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
        <group group_id="E2">
          <title>800 IU Vitamin D</title>
          <description>800 IU Vitamin D taken daily for six months&#xD;
Vitamin D: Vitamin D taken in two different dosages daily for six months.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Laura Graeff-Armas</name_or_title>
      <organization>University of Nebraska Medical Center</organization>
      <phone>402-559-6310</phone>
      <email>laura.armas@unmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

